カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界のプロゲステロン薬市場予測2023-2029：カプセル、錠剤、その他

【英語タイトル】Progesterone Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8607）・商品コード：MMG23LY8607
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：73
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のプロゲステロン薬市場規模と予測を収録しています。・世界のプロゲステロン薬市場：売上、2018年-2023年、2024年-2029年
・世界のプロゲステロン薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のプロゲステロン薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「カプセル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

プロゲステロン薬のグローバル主要企業は、Merck、 Pfizer、 BionPharma、 Teva Pharmaceutical Industries、 Aquatic Remedies、 Sofgen Pharmaceuticals、 Virtus Pharmaceuticals、 Intas Pharmaceuticals、 Zhejiang Xianju Pharmaceutical、 Hubei Dongxin Pharmaceutical、 Zhejiang Medicine、 Zhejiang Aisheng Pharmaceutical、 Beijing Winsunny Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、プロゲステロン薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のプロゲステロン薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のプロゲステロン薬市場：タイプ別市場シェア、2022年
・カプセル、錠剤、その他

世界のプロゲステロン薬市場：用途別、2018年-2023年、2024年-2029年
世界のプロゲステロン薬市場：用途別市場シェア、2022年
・病院、診療所、薬局、その他

世界のプロゲステロン薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のプロゲステロン薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるプロゲステロン薬のグローバル売上、2018年-2023年
・主要企業におけるプロゲステロン薬のグローバル売上シェア、2022年
・主要企業におけるプロゲステロン薬のグローバル販売量、2018年-2023年
・主要企業におけるプロゲステロン薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Merck、 Pfizer、 BionPharma、 Teva Pharmaceutical Industries、 Aquatic Remedies、 Sofgen Pharmaceuticals、 Virtus Pharmaceuticals、 Intas Pharmaceuticals、 Zhejiang Xianju Pharmaceutical、 Hubei Dongxin Pharmaceutical、 Zhejiang Medicine、 Zhejiang Aisheng Pharmaceutical、 Beijing Winsunny Pharmaceutical

*************************************************************

・調査・分析レポートの概要
プロゲステロン薬市場の定義
市場セグメント
世界のプロゲステロン薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のプロゲステロン薬市場規模
世界のプロゲステロン薬市場規模：2022年 VS 2029年
世界のプロゲステロン薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのプロゲステロン薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のプロゲステロン薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：カプセル、錠剤、その他
プロゲステロン薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、薬局、その他
プロゲステロン薬の用途別グローバル売上・予測

・地域別市場分析
地域別プロゲステロン薬市場規模 2022年と2029年
地域別プロゲステロン薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck、 Pfizer、 BionPharma、 Teva Pharmaceutical Industries、 Aquatic Remedies、 Sofgen Pharmaceuticals、 Virtus Pharmaceuticals、 Intas Pharmaceuticals、 Zhejiang Xianju Pharmaceutical、 Hubei Dongxin Pharmaceutical、 Zhejiang Medicine、 Zhejiang Aisheng Pharmaceutical、 Beijing Winsunny Pharmaceutical
...

Progesterone is used to help prevent changes in the uterus (womb) in women who are taking conjugated estrogens after menopause. It is also used to properly regulate the menstrual cycle and treat unusual stopping of menstrual periods (amenorrhea) in women who are still menstruating.
This report aims to provide a comprehensive presentation of the global market for Progesterone Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Progesterone Drugs. This report contains market size and forecasts of Progesterone Drugs in global, including the following market information:
Global Progesterone Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Progesterone Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Progesterone Drugs companies in 2022 (%)
The global Progesterone Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Capsules Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Progesterone Drugs include Merck, Pfizer, BionPharma, Teva Pharmaceutical Industries, Aquatic Remedies, Sofgen Pharmaceuticals, Virtus Pharmaceuticals, Intas Pharmaceuticals and Zhejiang Xianju Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Progesterone Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Progesterone Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Progesterone Drugs Market Segment Percentages, by Type, 2022 (%)
Capsules
Tablets
Others
Global Progesterone Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Progesterone Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Pharmacy
Other
Global Progesterone Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Progesterone Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Progesterone Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Progesterone Drugs revenues share in global market, 2022 (%)
Key companies Progesterone Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Progesterone Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Pfizer
BionPharma
Teva Pharmaceutical Industries
Aquatic Remedies
Sofgen Pharmaceuticals
Virtus Pharmaceuticals
Intas Pharmaceuticals
Zhejiang Xianju Pharmaceutical
Hubei Dongxin Pharmaceutical
Zhejiang Medicine
Zhejiang Aisheng Pharmaceutical
Beijing Winsunny Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Progesterone Drugs, market overview.
Chapter 2: Global Progesterone Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Progesterone Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Progesterone Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Progesterone Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Progesterone Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Progesterone Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Progesterone Drugs Overall Market Size
2.1 Global Progesterone Drugs Market Size: 2022 VS 2029
2.2 Global Progesterone Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Progesterone Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Progesterone Drugs Players in Global Market
3.2 Top Global Progesterone Drugs Companies Ranked by Revenue
3.3 Global Progesterone Drugs Revenue by Companies
3.4 Global Progesterone Drugs Sales by Companies
3.5 Global Progesterone Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Progesterone Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Progesterone Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Progesterone Drugs Players in Global Market
3.8.1 List of Global Tier 1 Progesterone Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Progesterone Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Progesterone Drugs Market Size Markets, 2022 & 2029
4.1.2 Capsules
4.1.3 Tablets
4.1.4 Others
4.2 By Type – Global Progesterone Drugs Revenue & Forecasts
4.2.1 By Type – Global Progesterone Drugs Revenue, 2018-2023
4.2.2 By Type – Global Progesterone Drugs Revenue, 2024-2029
4.2.3 By Type – Global Progesterone Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Progesterone Drugs Sales & Forecasts
4.3.1 By Type – Global Progesterone Drugs Sales, 2018-2023
4.3.2 By Type – Global Progesterone Drugs Sales, 2024-2029
4.3.3 By Type – Global Progesterone Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Progesterone Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Progesterone Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Pharmacy
5.1.5 Other
5.2 By Application – Global Progesterone Drugs Revenue & Forecasts
5.2.1 By Application – Global Progesterone Drugs Revenue, 2018-2023
5.2.2 By Application – Global Progesterone Drugs Revenue, 2024-2029
5.2.3 By Application – Global Progesterone Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Progesterone Drugs Sales & Forecasts
5.3.1 By Application – Global Progesterone Drugs Sales, 2018-2023
5.3.2 By Application – Global Progesterone Drugs Sales, 2024-2029
5.3.3 By Application – Global Progesterone Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Progesterone Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Progesterone Drugs Market Size, 2022 & 2029
6.2 By Region – Global Progesterone Drugs Revenue & Forecasts
6.2.1 By Region – Global Progesterone Drugs Revenue, 2018-2023
6.2.2 By Region – Global Progesterone Drugs Revenue, 2024-2029
6.2.3 By Region – Global Progesterone Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Progesterone Drugs Sales & Forecasts
6.3.1 By Region – Global Progesterone Drugs Sales, 2018-2023
6.3.2 By Region – Global Progesterone Drugs Sales, 2024-2029
6.3.3 By Region – Global Progesterone Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Progesterone Drugs Revenue, 2018-2029
6.4.2 By Country – North America Progesterone Drugs Sales, 2018-2029
6.4.3 US Progesterone Drugs Market Size, 2018-2029
6.4.4 Canada Progesterone Drugs Market Size, 2018-2029
6.4.5 Mexico Progesterone Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Progesterone Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Progesterone Drugs Sales, 2018-2029
6.5.3 Germany Progesterone Drugs Market Size, 2018-2029
6.5.4 France Progesterone Drugs Market Size, 2018-2029
6.5.5 U.K. Progesterone Drugs Market Size, 2018-2029
6.5.6 Italy Progesterone Drugs Market Size, 2018-2029
6.5.7 Russia Progesterone Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Progesterone Drugs Market Size, 2018-2029
6.5.9 Benelux Progesterone Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Progesterone Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Progesterone Drugs Sales, 2018-2029
6.6.3 China Progesterone Drugs Market Size, 2018-2029
6.6.4 Japan Progesterone Drugs Market Size, 2018-2029
6.6.5 South Korea Progesterone Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Progesterone Drugs Market Size, 2018-2029
6.6.7 India Progesterone Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Progesterone Drugs Revenue, 2018-2029
6.7.2 By Country – South America Progesterone Drugs Sales, 2018-2029
6.7.3 Brazil Progesterone Drugs Market Size, 2018-2029
6.7.4 Argentina Progesterone Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Progesterone Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Progesterone Drugs Sales, 2018-2029
6.8.3 Turkey Progesterone Drugs Market Size, 2018-2029
6.8.4 Israel Progesterone Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Progesterone Drugs Market Size, 2018-2029
6.8.6 UAE Progesterone Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Progesterone Drugs Major Product Offerings
7.1.4 Merck Progesterone Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Progesterone Drugs Major Product Offerings
7.2.4 Pfizer Progesterone Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 BionPharma
7.3.1 BionPharma Company Summary
7.3.2 BionPharma Business Overview
7.3.3 BionPharma Progesterone Drugs Major Product Offerings
7.3.4 BionPharma Progesterone Drugs Sales and Revenue in Global (2018-2023)
7.3.5 BionPharma Key News & Latest Developments
7.4 Teva Pharmaceutical Industries
7.4.1 Teva Pharmaceutical Industries Company Summary
7.4.2 Teva Pharmaceutical Industries Business Overview
7.4.3 Teva Pharmaceutical Industries Progesterone Drugs Major Product Offerings
7.4.4 Teva Pharmaceutical Industries Progesterone Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.5 Aquatic Remedies
7.5.1 Aquatic Remedies Company Summary
7.5.2 Aquatic Remedies Business Overview
7.5.3 Aquatic Remedies Progesterone Drugs Major Product Offerings
7.5.4 Aquatic Remedies Progesterone Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Aquatic Remedies Key News & Latest Developments
7.6 Sofgen Pharmaceuticals
7.6.1 Sofgen Pharmaceuticals Company Summary
7.6.2 Sofgen Pharmaceuticals Business Overview
7.6.3 Sofgen Pharmaceuticals Progesterone Drugs Major Product Offerings
7.6.4 Sofgen Pharmaceuticals Progesterone Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Sofgen Pharmaceuticals Key News & Latest Developments
7.7 Virtus Pharmaceuticals
7.7.1 Virtus Pharmaceuticals Company Summary
7.7.2 Virtus Pharmaceuticals Business Overview
7.7.3 Virtus Pharmaceuticals Progesterone Drugs Major Product Offerings
7.7.4 Virtus Pharmaceuticals Progesterone Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Virtus Pharmaceuticals Key News & Latest Developments
7.8 Intas Pharmaceuticals
7.8.1 Intas Pharmaceuticals Company Summary
7.8.2 Intas Pharmaceuticals Business Overview
7.8.3 Intas Pharmaceuticals Progesterone Drugs Major Product Offerings
7.8.4 Intas Pharmaceuticals Progesterone Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Intas Pharmaceuticals Key News & Latest Developments
7.9 Zhejiang Xianju Pharmaceutical
7.9.1 Zhejiang Xianju Pharmaceutical Company Summary
7.9.2 Zhejiang Xianju Pharmaceutical Business Overview
7.9.3 Zhejiang Xianju Pharmaceutical Progesterone Drugs Major Product Offerings
7.9.4 Zhejiang Xianju Pharmaceutical Progesterone Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Zhejiang Xianju Pharmaceutical Key News & Latest Developments
7.10 Hubei Dongxin Pharmaceutical
7.10.1 Hubei Dongxin Pharmaceutical Company Summary
7.10.2 Hubei Dongxin Pharmaceutical Business Overview
7.10.3 Hubei Dongxin Pharmaceutical Progesterone Drugs Major Product Offerings
7.10.4 Hubei Dongxin Pharmaceutical Progesterone Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Hubei Dongxin Pharmaceutical Key News & Latest Developments
7.11 Zhejiang Medicine
7.11.1 Zhejiang Medicine Company Summary
7.11.2 Zhejiang Medicine Progesterone Drugs Business Overview
7.11.3 Zhejiang Medicine Progesterone Drugs Major Product Offerings
7.11.4 Zhejiang Medicine Progesterone Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Zhejiang Medicine Key News & Latest Developments
7.12 Zhejiang Aisheng Pharmaceutical
7.12.1 Zhejiang Aisheng Pharmaceutical Company Summary
7.12.2 Zhejiang Aisheng Pharmaceutical Progesterone Drugs Business Overview
7.12.3 Zhejiang Aisheng Pharmaceutical Progesterone Drugs Major Product Offerings
7.12.4 Zhejiang Aisheng Pharmaceutical Progesterone Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Zhejiang Aisheng Pharmaceutical Key News & Latest Developments
7.13 Beijing Winsunny Pharmaceutical
7.13.1 Beijing Winsunny Pharmaceutical Company Summary
7.13.2 Beijing Winsunny Pharmaceutical Progesterone Drugs Business Overview
7.13.3 Beijing Winsunny Pharmaceutical Progesterone Drugs Major Product Offerings
7.13.4 Beijing Winsunny Pharmaceutical Progesterone Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Beijing Winsunny Pharmaceutical Key News & Latest Developments
8 Global Progesterone Drugs Production Capacity, Analysis
8.1 Global Progesterone Drugs Production Capacity, 2018-2029
8.2 Progesterone Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Progesterone Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Progesterone Drugs Supply Chain Analysis
10.1 Progesterone Drugs Industry Value Chain
10.2 Progesterone Drugs Upstream Market
10.3 Progesterone Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Progesterone Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Progesterone Drugs in Global Market
Table 2. Top Progesterone Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Progesterone Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Progesterone Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Progesterone Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Progesterone Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Progesterone Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Progesterone Drugs Product Type
Table 9. List of Global Tier 1 Progesterone Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Progesterone Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Progesterone Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Progesterone Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Progesterone Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Progesterone Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Progesterone Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Progesterone Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Progesterone Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Progesterone Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Progesterone Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Progesterone Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Progesterone Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Progesterone Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Progesterone Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Progesterone Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Progesterone Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Progesterone Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Progesterone Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Progesterone Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Progesterone Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Progesterone Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Progesterone Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Progesterone Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Progesterone Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Progesterone Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Progesterone Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Progesterone Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Progesterone Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Progesterone Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Progesterone Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Progesterone Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Progesterone Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Progesterone Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Progesterone Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Progesterone Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Progesterone Drugs Sales, (K Units), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck Progesterone Drugs Product Offerings
Table 48. Merck Progesterone Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Progesterone Drugs Product Offerings
Table 52. Pfizer Progesterone Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. BionPharma Company Summary
Table 55. BionPharma Progesterone Drugs Product Offerings
Table 56. BionPharma Progesterone Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. BionPharma Key News & Latest Developments
Table 58. Teva Pharmaceutical Industries Company Summary
Table 59. Teva Pharmaceutical Industries Progesterone Drugs Product Offerings
Table 60. Teva Pharmaceutical Industries Progesterone Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Teva Pharmaceutical Industries Key News & Latest Developments
Table 62. Aquatic Remedies Company Summary
Table 63. Aquatic Remedies Progesterone Drugs Product Offerings
Table 64. Aquatic Remedies Progesterone Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Aquatic Remedies Key News & Latest Developments
Table 66. Sofgen Pharmaceuticals Company Summary
Table 67. Sofgen Pharmaceuticals Progesterone Drugs Product Offerings
Table 68. Sofgen Pharmaceuticals Progesterone Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Sofgen Pharmaceuticals Key News & Latest Developments
Table 70. Virtus Pharmaceuticals Company Summary
Table 71. Virtus Pharmaceuticals Progesterone Drugs Product Offerings
Table 72. Virtus Pharmaceuticals Progesterone Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Virtus Pharmaceuticals Key News & Latest Developments
Table 74. Intas Pharmaceuticals Company Summary
Table 75. Intas Pharmaceuticals Progesterone Drugs Product Offerings
Table 76. Intas Pharmaceuticals Progesterone Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Intas Pharmaceuticals Key News & Latest Developments
Table 78. Zhejiang Xianju Pharmaceutical Company Summary
Table 79. Zhejiang Xianju Pharmaceutical Progesterone Drugs Product Offerings
Table 80. Zhejiang Xianju Pharmaceutical Progesterone Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Zhejiang Xianju Pharmaceutical Key News & Latest Developments
Table 82. Hubei Dongxin Pharmaceutical Company Summary
Table 83. Hubei Dongxin Pharmaceutical Progesterone Drugs Product Offerings
Table 84. Hubei Dongxin Pharmaceutical Progesterone Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Hubei Dongxin Pharmaceutical Key News & Latest Developments
Table 86. Zhejiang Medicine Company Summary
Table 87. Zhejiang Medicine Progesterone Drugs Product Offerings
Table 88. Zhejiang Medicine Progesterone Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Zhejiang Medicine Key News & Latest Developments
Table 90. Zhejiang Aisheng Pharmaceutical Company Summary
Table 91. Zhejiang Aisheng Pharmaceutical Progesterone Drugs Product Offerings
Table 92. Zhejiang Aisheng Pharmaceutical Progesterone Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Zhejiang Aisheng Pharmaceutical Key News & Latest Developments
Table 94. Beijing Winsunny Pharmaceutical Company Summary
Table 95. Beijing Winsunny Pharmaceutical Progesterone Drugs Product Offerings
Table 96. Beijing Winsunny Pharmaceutical Progesterone Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Beijing Winsunny Pharmaceutical Key News & Latest Developments
Table 98. Progesterone Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Progesterone Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Progesterone Drugs Production by Region, 2018-2023 (K Units)
Table 101. Global Progesterone Drugs Production by Region, 2024-2029 (K Units)
Table 102. Progesterone Drugs Market Opportunities & Trends in Global Market
Table 103. Progesterone Drugs Market Drivers in Global Market
Table 104. Progesterone Drugs Market Restraints in Global Market
Table 105. Progesterone Drugs Raw Materials
Table 106. Progesterone Drugs Raw Materials Suppliers in Global Market
Table 107. Typical Progesterone Drugs Downstream
Table 108. Progesterone Drugs Downstream Clients in Global Market
Table 109. Progesterone Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Progesterone Drugs Segment by Type in 2022
Figure 2. Progesterone Drugs Segment by Application in 2022
Figure 3. Global Progesterone Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Progesterone Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Progesterone Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Progesterone Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Progesterone Drugs Revenue in 2022
Figure 9. By Type - Global Progesterone Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Progesterone Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Progesterone Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Progesterone Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Progesterone Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Progesterone Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Progesterone Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Progesterone Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Progesterone Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Progesterone Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Progesterone Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Progesterone Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Progesterone Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Progesterone Drugs Sales Market Share, 2018-2029
Figure 23. US Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Progesterone Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Progesterone Drugs Sales Market Share, 2018-2029
Figure 28. Germany Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Progesterone Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Progesterone Drugs Sales Market Share, 2018-2029
Figure 37. China Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Progesterone Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Progesterone Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Progesterone Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Progesterone Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Progesterone Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Progesterone Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Progesterone Drugs by Region, 2022 VS 2029
Figure 54. Progesterone Drugs Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のプロゲステロン薬市場予測2023-2029：カプセル、錠剤、その他] (コード：MMG23LY8607)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のプロゲステロン薬市場予測2023-2029：カプセル、錠剤、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のリファマイシン市場予測2023-2029：タブレット、カプセル
  • 世界のステアリン酸マグネシウム賦形剤市場予測2023-2029：粉末、粒状、錠剤、カプセル、滴丸剤、その他
  • 世界のセロトニンサプリメント市場予測2023-2029：錠剤、カプセル、その他
  • 世界の高齢者用カルシウム錠剤市場予測2023-2029：液体、錠剤、カプセル
  • 世界の腎臓病治療薬市場2022年：錠剤、カプセル、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆